Gérald Cruciani
|
|
||||
| Faculté ou Centre | Luxembourg Centre for Systems Biomedicine | ||||
| Department | Scientific Central Services | ||||
| Adresse postale |
Université du Luxembourg 6, avenue du Swing L-4367 Belvaux |
||||
| Bureau sur le campus | BioTech II, 2.19 | ||||
|
|||||
| Téléphone | (+352) 46 66 44 6940 | ||||
Technician in the Translational Neuroscience group (Krüger Lab), specialised in automation.
Last updated on: mardi 30 juin 2020
powered by
2021
Gene-corrected p.A30P SNCA patient-derived isogenic neurons rescue neuronal branching and function; ; ; ; ; ; ; ; ; ;
in Scientific Reports (2021), 11
Integrated, automated maintenance, expansion and differentiation of 2D and 3D patient-derived cellular models for high throughput drug screening; ; ; ; ; ; ; ; ;
in Scientific Reports (2021)
Parkinson’s disease phenotypes in patient neuronal cultures and brain organoids improved by 2-Hydroxypropyl-b-Cyclodextrin treatment; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
in Movement Disorders (2021)
2020
Generation of two iPS cell lines (HIHDNDi001-A and HIHDNDi001-B) from a Parkinson's disease patient carrying the heterozygous p.A30P mutation in SNCA.; ; ; ; ; ;
in Stem cell research (2020), 48
Induced pluripotent stem cell line (LCSBi001-A) derived from a patient with Parkinson's disease carrying the p.D620N mutation in VPS35; ; ; ; ; ;
in Stem Cell Research (2020)
